USA-Belgium Bilateral Trade Analysis 2023

Complete trade statistics: $56.36B total volume โ€ขUSA surplus: $11.30B

USA โ†’ Belgium

$33.83B

Exports (2023)

Belgium โ†’ USA

$22.53B

Imports (2023)

Trade Balance

$11.30B

Surplus for USA

Total Trade

$56.36B

Combined Volume

Trade Flow Visualization

Direct trade relationship between USA and Belgium. Green line shows exports from USA, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the USA-Belgium commercial relationship and competitive positioning in global markets.

USA โ†’ Belgium Exports

$33.83B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
11.6% top product
1Vaccines: for human medicine
$3.93B
11.6% of exports
2Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$2.42B
7.1% of exports
3Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$1.34B
4.0% of exports
4Diamonds: non-industrial, (other than unworked or simply sawn, cleaved or bruted), but not mounted or set
$1.31B
3.9% of exports
5Medical, surgical or dental instruments and appliances: n.e.c. in heading no. 9018
$861.87M
2.5% of exports
6Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$829.83M
2.5% of exports
7Petroleum gases and other gaseous hydrocarbons: liquefied, natural gas
$796.66M
2.4% of exports
8Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$755.73M
2.2% of exports
9Petroleum gases and other gaseous hydrocarbons: liquefied, propane
$587.34M
1.7% of exports
10Medical, surgical instruments and appliances: catheters, cannulae and the like
$565.51M
1.7% of exports

๐ŸŽฏ Strategic Export Focus

USA's export portfolio to Belgium demonstrates strong diversification across multiple sectors, with vaccines: for human medicine representing a key competitive advantage in this bilateral market.

Belgium โ†’ USA Imports

$22.53B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
14.3% concentration
1Vaccines: for human medicine
$3.23B
14.3% of imports
2Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$2.57B
11.4% of imports
3Diamonds: non-industrial, (other than unworked or simply sawn, cleaved or bruted), but not mounted or set
$1.70B
7.5% of imports
4Vehicles: with only electric motor for propulsion
$1.48B
6.6% of imports
5Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$1.28B
5.7% of imports
6Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$1.27B
5.6% of imports
7Vehicles: with only spark-ignition internal combustion reciprocating piston engine, cylinder capacity over 1500 but not over 3000cc
$955.99M
4.2% of imports
8Metals: rhodium, unwrought or in powder form
$289.06M
1.3% of imports
9Vegetable preparations: potatoes, prepared or preserved otherwise than by vinegar or acetic acid, frozen
$273.00M
1.2% of imports
10Paintings, drawings and pastels: executed entirely by hand, other than drawings of heading no. 4906
$262.26M
1.2% of imports

๐Ÿ“ฆ Import Strategy Analysis

USA's import pattern from Belgium reveals significant dependencyin vaccines: for human medicine, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

USA demonstrates competitive strength in exportingvaccines: for human medicine to Belgium, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.

Specialized Exchange
๐Ÿ“ˆ

Growth Potential

The $56.36B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: USA-Belgium Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $56.36 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: USA maintains a surplus of $11.30 billion
  • Export Focus: USA's primary exports include vaccines: for human medicine, medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
  • Import Dependencies: Key imports from Belgium include vaccines: for human medicine, medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, diamonds: non-industrial, (other than unworked or simply sawn, cleaved or bruted), but not mounted or set

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthImbalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents one of the world's largest trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $56.36B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with USA leveraging its comparative advantages in vaccines: for human medicine.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

USA's specialization in vaccines: for human medicinecomplements Belgium's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in vaccines: for human medicine.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $56.36B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyModerate
๐Ÿ”ฎ

Trade Relationship Outlook

The $56.36B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $56.36 billion bilateral trade volume represents a major economic driverfor both economies.

Economic Significance: Very High
๐Ÿญ

Industrial Integration

Trade flows in vaccines: for human medicine and vaccines: for human medicine demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

USA's trade surplus of $11.30 billion strengthens its overall economic position in this bilateral relationship.

Balance Impact: Export Advantage

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale present expansion opportunities.
Market Diversification
Beyond current focus on vaccines: for human medicine, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in vaccines: for human medicine may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between USA and Belgium represents a total trade volume of $56.36 billion in 2023. This partnership demonstrates a favorable trade balance for USA, with exports exceeding importsby $11.30 billion.

Export Strengths

USA's exports to Belgium total $33.83 billion, with competitive advantages in vaccines: for human medicine, representing $3.93B or11.6% of bilateral exports.

Import Dependencies

Imports from Belgium amount to $22.53 billion, highlighting economic interdependence in vaccines: for human medicine, with Vaccines: for human medicine comprising14.3% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates USA's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between USA and Belgium in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023